What We're Reading
Industry reads hand-picked by our editors
Jun 24, 2022
-
The Wall Street Journal
Merck Pushes Forward With Potential Deal for Seagen
-
Bloomberg
Covid Vaccines Prevented 20 Million Deaths in First Year, Study Finds
-
Reuters
Roche sceptical about investing more in 'guided-missile' ADC cancer drugs
-
Biotech Strategy Blog
An alternate perspective on TIGIT
Jun 23, 2022
-
The Wall Street Journal
Americans With ALS Look to Canada for Promising Drug the U.S. Hasn’t Approved
-
The Boston Globe
DEM BioPharma launches with $70m to take a bite out of cancer
-
The New York Times
F.D.A. Aims to Slash Nicotine Levels in Cigarettes
Jun 22, 2022
Jun 21, 2022
-
Bloomberg
Forget Crypto Winter. In Biotech, It’s Been Freezing for Months
-
The Wall Street Journal
Can We Develop a Covid-19 Vaccine That Lasts?
-
BioSpace
Acadia's Alzheimer’s Drug Voted Down by FDA Advisory Committee
-
Nature Medicine
Four areas of health innovation boosted by the pandemic
Jun 17, 2022
Jun 16, 2022
-
MedCity News
November will bring political change. Will it also change drug prices and PDUFA?
-
The Washington Post
WHO to rename monkeypox after scientists call it ‘discriminatory’
-
Chemical & Engineering News
Molecular glue firms get investment, strike partnerships
-
Bloomberg
Goldman Backs Biotech Firm in Volatile Year for China Deals
Jun 15, 2022
-
FierceBiotech
BIO'22 marked by first-time handshakes and attempts at survival
-
The Atlantic
Monkeypox Vaccines Are Too Gnarly for the Masses
-
Financial Times
Investors bet on AI start-ups to turbocharge drug development
-
Associated Press
FDA advisers back Moderna's COVID-19 vaccine for older kids
